Publication | Closed Access

Botulinum toxin type A ameliorates adjuvant-arthritis pain by inhibiting microglial activation-mediated neuroinflammation and intracellular molecular signaling

InflammationRheumatologyPain SyndromeAnti-inflammatoryAutoimmune DiseaseIntracellular MolecularPain MedicineMedicineImmunologyNeuropathic PainMolecular PainInflammatory Rheumatic DiseaseBotulinum Toxin TypePharmacologyNeuroimmunologyAdjuvant-arthritis PainRheumatoid ArthritisPain Research